ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
2.320
-0.040 (-1.69%)
At close: Jul 11, 2025, 4:00 PM
2.500
+0.180 (7.76%)
After-hours: Jul 11, 2025, 6:43 PM EDT

ProQR Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover ProQR Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $8.88, which forecasts a 282.76% increase in the stock price over the next year. The lowest target is $4 and the highest is $14.

Price Target: $8.88 (+282.76%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $4.00 $8.88 $9.00 $14
Change +72.41% +282.76% +287.93% +503.45%

Analyst Ratings

The average analyst rating for ProQR Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Feb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy 444444
Buy 112344
Hold 110000
Sell 000000
Strong Sell 000000
Total 666788

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$8
Buy Reiterates $8 +244.83% Jun 27, 2025
JMP Securities
JMP Securities
Buy
Reiterates
$8
Buy Reiterates $8 +244.83% Jun 27, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$15$9
Buy Maintains $15$9 +287.93% May 13, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Initiates
$5
Buy Initiates $5 +115.52% Apr 29, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$4
Strong Buy Maintains $4 +72.41% Mar 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
17.86M
from 19.55M
Decreased by -8.64%
Revenue Next Year
12.84M
from 17.86M
Decreased by -28.10%
EPS This Year
-0.39
from -0.32
EPS Next Year
-0.51
from -0.39
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
1.03M2.38M4.36M6.59M19.55M17.86M12.84M8.89M
Revenue Growth
-46.77% 131.10% 83.30% 51.27% 196.41% -8.64% -28.10% -30.77%
EPS
-0.93-0.95-0.90-0.35-0.32-0.39-0.51-0.52
EPS Growth
- - - - - - - -
Forward PE
--------
No. Analysts
-----10107
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 37.7M 21.5M 20.1M
Avg 17.9M 12.8M 8.9M
Low 4.3M n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High
92.9%
20.3%
56.7%
Avg
-8.6%
-28.1%
-30.8%
Low
-78.1%
- -

EPS Forecast

EPS 202520262027
High -0.25 -0.33 -0.36
Avg -0.39 -0.51 -0.52
Low -0.50 -0.79 -0.71

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.